Autologous bone marrow-derived adult stem cell therapy (TCA Cellular Therapy)

N/A

Report date: 2022/11/25 17:01:18

Base Information

Drug NameAutologous bone marrow-derived adult stem cell therapy (TCA Cellular Therapy)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord InjuriesAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTca Cellular Therapy Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTca Cellular Therapy Llc
Active IndicationsN/A
Inactive IndicationsSpinal Cord InjuriesAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A